Cell experiments showed consistent results that MEG3 (P < 0.01) and CNN1 expression levels (P < 0.05) were markedly decreased in human breast cancer cells MCF-7, BT-474, and MDA-MB-468 compared to those in non-cancerous human breast epithelial cells MCF10A. The gene discussed is MEG3; the disease is breast carcinoma.